Anti-PD 1 Brain Collaboration + Radiotherapy Extension (ABC-X Study)

NCT03340129 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

218

Enrollment

OTHER

Sponsor class

Conditions

Melanoma Stage Iv

Interventions

DRUG: Ipilimumab
DRUG: Nivolumab
RADIATION: Stereotactic Radiotherapy
OTHER: Salvage therapy

Sponsor

Melanoma Institute Australia

Collaborators

[object Object]